Direct-Compression (DC) Grade Granules

Direct-Compression (DC) grade granules represent precision-engineered particulate systems purpose-built to confer optimal flowability, compressibility, compactibility, and die-fill uniformity for tablet manufacture obviating conventional wet- or dry-granulation unit operations immediately prior to compression. For liposomal vitamin and nutraceutical payloads, DC-grade granule architecture is bespoke-engineered to accommodate the physicochemical sensitivities and payload-loading constraints intrinsic to vesicular actives.

The granulation matrix is systematically optimized to deliver a tightly controlled particle-size distribution, narrow granulometric envelope, targeted bulk/tapped density ratio, minimized segregation potential, and superior Carr’s/Hausner-validated flow classification. Critical Material Attributes and Critical Process Parameters are established under a framework to guarantee reproducible die filling, consistent tablet weight uniformity, adequate mechanical strength, and homogeneous active distribution throughout the compact. Particular emphasis is placed on preserving phospholipid bilayer integrity and vesicular functional performance across granulation, fluid-bed drying, lubricant blending, and compression unit operations. The finalized DC granules must demonstrate pharmaceutically robust compressibility, compactibility, ejection-force profile, and tabletability indices, thereby ensuring manufacturing robustness and mitigating classical compression-induced defects including capping, lamination, sticking/picking, and inter-tablet weight variability.

Key Technical Development Parameters

• Flow-property optimization: Precision control of particle morphology, granulometric distribution, bulk density, Carr’s Index, Hausner Ratio, and dynamic/static flow-rate kinetics.
• Compression-performance engineering: Optimization of compressibility indices, compactibility profiles, tabletability, tensile strength, and disintegration kinetics.
• Segregation-risk mitigation: Development of a homogeneous granular matrix minimizing density- and PSD-driven demixing tendencies.
• Liposomal-integrity preservation: Quantitative evaluation of processing-induced shifts in vesicle particle size, PDI, zeta potential, encapsulation efficiency, and chemical potency.
• Manufacturing-robustness validation: Systematic optimization of lubrication ratio, blending uniformity, compression force–hardness correlation, dwell time, turret speed, and ejection-force profiling.